Ticker | $ Bought |
---|---|
intra-cellular therapies inc | 12,340,100 |
axsome therapeutics inc | 5,640,190 |
soleno therapeutics inc | 3,938,920 |
korro bio inc | 2,690,710 |
eyepoint pharmaceuticals inc | 2,592,600 |
aadi bioscience inc | 2,580,600 |
atyr pharma inc | 2,533,020 |
89bio inc | 2,485,450 |
Ticker | % Inc. |
---|---|
alumis inc | 6.42 |
Ticker | % Reduced |
---|---|
springworks therapeutics inc | -75.98 |
jasper therapeutics inc | -69.35 |
mind medicine mindmed inc | -58.11 |
edgewise therapeutics inc | -55.69 |
blueprint medicines corp | -47.31 |
tarsus pharmaceuticals inc | -46.21 |
merus n v | -43.91 |
trevi therapeutics inc | -40.92 |
Ticker | $ Sold |
---|---|
relay therapeutics inc | -4,432,490 |
applied therapeutics inc | -5,255,820 |
perspective therapeutics inc | -4,562,220 |
kura oncology inc | -5,746,340 |
longboard pharmaceuticals in | -8,028,930 |
revolution medicines inc | -7,414,720 |
disc medicine inc | -4,914,000 |
sarepta therapeutics inc | -8,992,080 |
Ally Bridge Group (NY) LLC has about 85.7% of it's holdings in Healthcare sector.
Sector | % |
---|---|
Healthcare | 85.7 |
Others | 14.3 |
Ally Bridge Group (NY) LLC has about 6.8% of it's portfolio invested in the large-cap and mega-cap stocks.
Category | % |
---|---|
MID-CAP | 37.3 |
SMALL-CAP | 28.4 |
UNALLOCATED | 14.3 |
MICRO-CAP | 9.8 |
LARGE-CAP | 6.8 |
NANO-CAP | 3.5 |
About 57% of the stocks held by Ally Bridge Group (NY) LLC either belong to S&P 500 or RUSSELL 2000 index.
Index | % |
---|---|
RUSSELL 2000 | 57 |
Others | 43 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Ally Bridge Group (NY) LLC has 30 stocks in it's portfolio. About 55.1% of the portfolio is in top 10 stocks. ELYM proved to be the most loss making stock for the portfolio. TARS was the most profitable stock for Ally Bridge Group (NY) LLC last quarter.
Last Reported on: 14 Feb, 2025Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
---|---|---|---|---|---|---|---|---|
AADI | aadi bioscience inc | 2.21 | 817,939 | 2,580,600 | new | |||
APLT | applied therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
AXSM | axsome therapeutics inc | 4.84 | 66,661 | 5,640,190 | new | |||
BPMC | blueprint medicines corp | 4.18 | 55,892 | 4,874,900 | reduced | -47.31 | ||
CNTA | centessa pharmaceuticals plc | 3.51 | 244,538 | 4,096,010 | reduced | -21.02 | ||
CNTX | context therapeutics inc | 1.42 | 1,576,760 | 1,655,600 | reduced | -10.29 | ||
ELYM | climb bio inc | 1.17 | 760,225 | 1,368,400 | reduced | -38.16 | ||
ETNB | 89bio inc | 2.13 | 317,833 | 2,485,450 | new | |||
EWTX | edgewise therapeutics inc | 1.90 | 83,176 | 2,220,800 | reduced | -55.69 | ||
EYPT | eyepoint pharmaceuticals inc | 2.22 | 348,000 | 2,592,600 | new | |||
GERN | geron corp | 3.26 | 1,074,820 | 3,804,880 | reduced | -19.25 | ||
INSM | insmed inc | 6.77 | 114,360 | 7,895,410 | reduced | -24.18 | ||
ITCI | intra-cellular therapies inc | 10.58 | 147,750 | 12,340,100 | new | |||
JANX | janux therapeutics inc | 4.14 | 90,292 | 4,834,230 | reduced | -17.02 | ||
JSPR | jasper therapeutics inc | 2.24 | 122,424 | 2,617,420 | reduced | -69.35 | ||
KURA | kura oncology inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
LBPH | longboard pharmaceuticals in | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
LIFE | atyr pharma inc | 2.17 | 699,730 | 2,533,020 | new | |||
MNMD | mind medicine mindmed inc | 1.97 | 330,275 | 2,298,710 | reduced | -58.11 | ||
MRUS | merus n v | 4.21 | 116,796 | 4,911,270 | reduced | -43.91 | ||